ORLANDO (EGMN) - Adjuvant chemoradiation with cisplatin, 5-fluorouracil, and interferon-alfa for resected pancreatic cancer increased the 18-month overall survival in 53 of 79 patients but at a price - severe grade 3/4 toxicity in virtually all who received the treatment.The protocol was initially tested in 53 patients at Virginia Mason Medical Center, Seattle, between 1995 and 2001. The median survival was 39 months, the 2-year survival was 51%, and 5-year survival was 41%, Dr. Vincent J. Picozzi...